NEW YORK (GenomeWeb News) – Bio-Rad Laboratories reported after the close of the market on Tuesday that first quarter revenues were nearly flat year over year, as the company missed consensus Wall Street estimates on the top and bottom line.

For the three months ended March 31, revenues totaled $486.3 million, up a fraction of 1 percent from $485.1 million a year ago. Analyst estimates had revenues for the quarter at $492.4 million.

On a currency-neutral basis, revenues rose around 1 percent year over year, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.